We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEF
3351
DELISTED
Telefonica
TEF
$22K ﹤0.01%
5,108
+4,212
+470% +$16.7K
TLS icon
3352
Telos
TLS
$339M
$22K ﹤0.01%
8,708
-6,173
-41% -$25.2K
TRUE
3353
DELISTED
TrueCar
TRUE
$22K ﹤0.01%
9,575
+3,340
+54% +$8.91K
UNIT
3354
Uniti Group
UNIT
$2.43B
$22K ﹤0.01%
6,204
+3,865
+165% +$20.5K
UTMD icon
3355
Utah Medical Products
UTMD
$226M
$22K ﹤0.01%
228
+141
+162% +$13K
VERU icon
3356
Veru
VERU
$46.5M
$22K ﹤0.01%
1,867
+1,648
+753% +$66.7K
VGK icon
3357
Vanguard FTSE Europe ETF
VGK
$31.1B
$22K ﹤0.01%
368
-171
-32% -$10.2K
WWW icon
3358
Wolverine World Wide
WWW
$1.72B
$22K ﹤0.01%
1,312
-11,108
-89% -$169K
LGF.A
3359
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$22K ﹤0.01%
2,045
+1,456
+247% +$13.1K
MKFG
3360
DELISTED
Markforged Holding Corporation
MKFG
$22K ﹤0.01%
2,324
+1,666
+253% +$20.7K
CMRX
3361
DELISTED
Chimerix, Inc.
CMRX
$22K ﹤0.01%
17,455
-7,819
-31% -$12.8K
PNT
3362
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$22K ﹤0.01%
3,081
+1,340
+77% +$9.94K
ABST
3363
DELISTED
Absolute Software Corp
ABST
$22K ﹤0.01%
2,893
+196
+7% +$1.91K
BSGA
3364
DELISTED
Blue Safari Group Acquisition Corp. Class A Ordinary Share
BSGA
$22K ﹤0.01%
1,992
-22
-1% -$234
AAT
3365
American Assets Trust
AAT
$1.4B
$21K ﹤0.01%
1,129
+534
+90% +$13K
AMPY icon
3366
Amplify Energy
AMPY
$198M
$21K ﹤0.01%
3,023
+2,918
+2,779% +$24K
GOLD
3367
Gold.com Inc
GOLD
$1.28B
$21K ﹤0.01%
604
+288
+91% +$9.58K
ANIK icon
3368
Anika Therapeutics
ANIK
$288M
$21K ﹤0.01%
720
-3,575
-83% -$106K
ANIP icon
3369
ANI Pharmaceuticals
ANIP
$1.76B
$21K ﹤0.01%
517
+227
+78% +$9.57K
BBAI icon
3370
BigBear.ai
BBAI
$1.57B
$21K ﹤0.01%
+8,602
New +$22.9K
BKD icon
3371
Brookdale Senior Living
BKD
$3.02B
$21K ﹤0.01%
7,323
+3,035
+71% +$8.71K
SRTA
3372
Strata Critical Medical Inc
SRTA
$522M
$21K ﹤0.01%
6,342
+5,865
+1,230% +$23.9K
CIA icon
3373
Citizens
CIA
$201M
$21K ﹤0.01%
5,602
-673
-11% -$1.86K
CLPT icon
3374
ClearPoint Neuro
CLPT
$468M
$21K ﹤0.01%
2,423
+1,717
+243% +$15K
CMPR icon
3375
Cimpress
CMPR
$2.3B
$21K ﹤0.01%
470
+196
+72% +$6.69K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.